Eyenovia announces appointment of Andrew Jones as CFO

Eyenovia (EYEN) announced the appointment of experienced finance and accounting executive Andrew Jones as Chief Financial Officer. Mr. Jones brings to the Eyenovia team more than 30 years of diverse finance and accounting leadership experience spanning therapeutics and medical technology/devices, most recently serving as Chief Financial Officer of NovaBay Pharmaceuticals (NBY), a publicly traded, commercial stage ophthalmic company. Eyenovia’s current CFO, John Gandolfo, is retiring and will remain with the Company through November to help ensure a smooth transition